BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 30755141)

  • 1. Evolution of retinal changes measured by optical coherence tomography in the assessment of hydroxychloroquine ocular safety in patients with systemic lupus erythematosus.
    Martín-Iglesias D; Artaraz J; Fonollosa A; Ugarte A; Arteagabeitia A; Ruiz-Irastorza G
    Lupus; 2019 Apr; 28(4):555-559. PubMed ID: 30755141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative assessment of outer retinal layers and ellipsoid zone mapping in hydroxychloroquine retinopathy.
    Ugwuegbu O; Uchida A; Singh RP; Beven L; Hu M; Kaiser S; Srivastava SK; Ehlers JP
    Br J Ophthalmol; 2019 Jan; 103(1):3-7. PubMed ID: 30190364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinal toxicity related to hydroxychloroquine in patients with systemic lupus erythematosus and rheumatoid arthritis.
    Telek HH; Yesilirmak N; Sungur G; Ozdemir Y; Yesil NK; Ornek F
    Doc Ophthalmol; 2017 Dec; 135(3):187-194. PubMed ID: 28852896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spectral domain optical coherence tomography for early detection of retinal alterations in patients using hydroxychloroquine.
    Ulviye Y; Betul T; Nur TH; Selda C
    Indian J Ophthalmol; 2013 Apr; 61(4):168-71. PubMed ID: 23685488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of hydroxychloroquine retinopathy with long-term use in a cohort of Indian patients with rheumatic diseases.
    Manoj M; Sahoo RR; Singh A; Hazarika K; Bafna P; Kaur A; Wakhlu A
    Rheumatol Int; 2021 May; 41(5):929-937. PubMed ID: 33704526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for hydroxychloroquine retinopathy in systemic lupus erythematosus: a case-control study with hydroxychloroquine blood-level analysis.
    Lenfant T; Salah S; Leroux G; Bousquet E; Le Guern V; Chasset F; Francès C; Morel N; Chezel J; Papo T; Cacoub P; Mouthon L; Guettrot-Imbert G; Cohen P; Régent A; Mauget-Faÿsse M; Piette JC; Jallouli M; Costedoat-Chalumeau N;
    Rheumatology (Oxford); 2020 Dec; 59(12):3807-3816. PubMed ID: 32442312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydroxychloroquine retinopathy: an emerging problem.
    Latasiewicz M; Gourier H; Yusuf IH; Luqmani R; Sharma SM; Downes SM
    Eye (Lond); 2017 Jun; 31(6):972-976. PubMed ID: 28186509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visual Impact of Early Hydroxychloroquine-Related Retinal Structural Changes in Patients with Systemic Lupus Erythematosus.
    Sallam MA; Beltagi AS; Abdellatif MA; Awadalla MA
    Ophthalmologica; 2021; 244(4):301-308. PubMed ID: 34015786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The incidence of irreversible retinal toxicity in patients treated with hydroxychloroquine: a reappraisal.
    Mavrikakis I; Sfikakis PP; Mavrikakis E; Rougas K; Nikolaou A; Kostopoulos C; Mavrikakis M
    Ophthalmology; 2003 Jul; 110(7):1321-6. PubMed ID: 12867385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Structural Changes on Multifocal Electroretinography in Patients With Use of Hydroxychloroquine.
    Borrelli E; Battista M; Cascavilla ML; Viganò C; Borghesan F; Nicolini N; Clemente L; Sacconi R; Barresi C; Marchese A; Miserocchi E; Modorati G; Bandello F; Querques G
    Invest Ophthalmol Vis Sci; 2021 Sep; 62(12):28. PubMed ID: 34581725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. En Face Optical Coherence Tomography Imaging of the Photoreceptor Layers in Hydroxychloroquine Retinopathy.
    Ahn SJ; Joung J; Lee BR
    Am J Ophthalmol; 2019 Mar; 199():71-81. PubMed ID: 30448463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LONGITUDINAL CHANGES IN EYES WITH HYDROXYCHLOROQUINE RETINAL TOXICITY.
    Allahdina AM; Chen KG; Alvarez JA; Wong WT; Chew EY; Cukras CA
    Retina; 2019 Mar; 39(3):473-484. PubMed ID: 30741731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macular ganglion cell-inner plexiform layer thickness for detection of early retinal toxicity of hydroxychloroquine.
    Kan E; Yakar K; Demirag MD; Gok M
    Int Ophthalmol; 2018 Aug; 38(4):1635-1640. PubMed ID: 28695378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of the regression on hydroxychloroquine retinopathy in optical coherence tomography.
    Turgut B; Turkcuoglu P; Serdar Koca S; Aydemir O
    Clin Rheumatol; 2009 May; 28(5):607-9. PubMed ID: 19221829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macula pigment optical densitometry changes in hydroxychloroquine use.
    Kabataş N; Özateş S; Avarisli NA; Kakil SB; Özişler C
    Cutan Ocul Toxicol; 2021 Jun; 40(2):115-118. PubMed ID: 33757380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spectral-domain optical coherence tomography and adaptive optics may detect hydroxychloroquine retinal toxicity before symptomatic vision loss.
    Stepien KE; Han DP; Schell J; Godara P; Rha J; Carroll J
    Trans Am Ophthalmol Soc; 2009 Dec; 107():28-33. PubMed ID: 20126479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Localization of damage in progressive hydroxychloroquine retinopathy on and off the drug: inner versus outer retina, parafovea versus peripheral fovea.
    de Sisternes L; Hu J; Rubin DL; Marmor MF
    Invest Ophthalmol Vis Sci; 2015 May; 56(5):3415-26. PubMed ID: 26024126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of Microperimetry in Detecting Early Retinal Toxicity of Hydroxychloroquine in Children with Juvenile Systemic Lupus Erythematosus.
    Youssef MM; El-Fayoumi D; Sidky MK; Hegazy AI; Marzouk H; Eltanamly RM
    Ophthalmologica; 2017; 237(3):180-184. PubMed ID: 28297699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macular retinal ganglion cell-inner plexiform layer thickness in patients on hydroxychloroquine therapy.
    Lee MG; Kim SJ; Ham DI; Kang SW; Kee C; Lee J; Cha HS; Koh EM
    Invest Ophthalmol Vis Sci; 2014 Nov; 56(1):396-402. PubMed ID: 25425304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RetINal Toxicity And HydroxyChloroquine Therapy (INTACT): protocol for a prospective population-based cohort study.
    Daftarian N; Lima A; Marozoff S; Ojo D; Levasseur SD; Maberley DAL; Hoens A; Esdaile J; Dawes M; Aviña-Zubieta JA; Adante B; Bhui RD; Bhui SB; Butler M; Chui L; Erasmus M; Etminan M; Godinho D; Hay E; Hollands H; Hoonjan M; Joe A; Lukaris A; Mammo Z; Navajas E; Pakzad-Vaezi K; Sanmugasunderam S; Shojania K;
    BMJ Open; 2022 Feb; 12(2):e053852. PubMed ID: 35177450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.